AstraZeneca PLC
NASDAQ:AZN

Watchlist Manager
AstraZeneca PLC Logo
AstraZeneca PLC
NASDAQ:AZN
Watchlist
Price: 78.02 USD -0.37% Market Closed
Market Cap: 241.9B USD
Have any thoughts about
AstraZeneca PLC?
Write Note

AstraZeneca PLC
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

AstraZeneca PLC
Cash Equivalents Peer Comparison

Comparables:
GSK
INDV
HIK
DPH
A
APH

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
AstraZeneca PLC
LSE:AZN
Cash Equivalents
$6.9B
CAGR 3-Years
-24%
CAGR 5-Years
5%
CAGR 10-Years
3%
GlaxoSmithKline PLC
LSE:GSK
Cash Equivalents
ÂŁ3B
CAGR 3-Years
-5%
CAGR 5-Years
-6%
CAGR 10-Years
-1%
Indivior PLC
LSE:INDV
Cash Equivalents
$302m
CAGR 3-Years
-33%
CAGR 5-Years
-21%
CAGR 10-Years
39%
Hikma Pharmaceuticals PLC
LSE:HIK
Cash Equivalents
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dechra Pharmaceuticals PLC
LSE:DPH
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
Alliance Pharma PLC
LSE:APH
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is AstraZeneca PLC's Cash Equivalents?
Cash Equivalents
6.9B USD

Based on the financial report for Jun 30, 2024, AstraZeneca PLC's Cash Equivalents amounts to 6.9B USD.

What is AstraZeneca PLC's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
3%

Over the last year, the Cash Equivalents growth was 22%. The average annual Cash Equivalents growth rates for AstraZeneca PLC have been -24% over the past three years , 5% over the past five years , and 3% over the past ten years .

Back to Top